Structure-Function Analysis of Human Immunodeficiency Virus Type 1 gp120 Amino Acid Mutations Associated with Resistance to the CCR5 Coreceptor Antagonist Vicriviroc
Robert A. Ogert(Merck & Co., Inc., Rahway, NJ, USA (United States)), John A. Howe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert Ralston(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter Buontempo, Catherine Buontempo, José S. Duca(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yan Hou(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lei Ba(Aaron Diamond AIDS Research Center)
Cited by 32
Related Papers
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272